General Surgery Devices are used in diagnostic and surgical interventions primarily for the gastrointestinal tract, abdomen, and pelvis. Robotic Surgical Systems are designed to work around the limitations still present in Minimally Invasive Surgical (MIS) interventions by improving surgeon’s accuracy and facilitating difficult interventions. GlobalData uses proprietary data and analytics to provide a comprehensive report on the robotic surgical systems devices market, including market shares of different players within Australia. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the robotic surgical systems market in Australia was Intuitive Surgical followed by Auris Health, Stryker, Zimmer Biomet Robotics, Mazor Robotics, Blue Belt Technologies, Globus Medical and Depuy Synthes.
Robotic Surgical Systems are passive devices controlled by a surgeon, and typically consist of a patient side cart, a surgeon console, and a vision system. These Robotic Surgical Systems exist for an array of indications, from all-purpose systems indicated for a variety of general surgery interventions to specialized systems. Both general and specialized systems are considered under Robotic Surgical Systems. Orthopedic Robotic Surgical Systems are specialized to improve surgical outcomes for indications that cover orthopedic surgeries. General Surgery Robotic Surgical Systems are specialized to cover various indications. Neurosurgery Robotic Surgical Systems are specialized to perform complex surgeries which are comparatively more sensitive.
The value of the robotic surgical systems devices market within Australia was expected to be over $40m in 2023.
For the latest complete market share analysis of robotic surgical systems device market in Australia, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
